<SEC-DOCUMENT>0001144204-15-061246.txt : 20151028
<SEC-HEADER>0001144204-15-061246.hdr.sgml : 20151028
<ACCEPTANCE-DATETIME>20151028163025
ACCESSION NUMBER:		0001144204-15-061246
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20151028
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151028
DATE AS OF CHANGE:		20151028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO BIOSCIENCES INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		151180609

	BUSINESS ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v423029_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Washington,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CURRENT
REPORT Pursuant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>to
Section 13 or 15(d) of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Securities
Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Date of report (Date
of earliest event reported)<U>: October 28, 2015</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid"><B>SANGAMO
BIOSCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in
Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid">Delaware</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or Other Jurisdiction of Incorporation)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>000-30171</B></FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>68-0359556</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(IRS Employer Identification No.)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>501 Canal Blvd, Suite A100</B></FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Richmond, California 94804</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address of Principal Executive Offices)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Zip Code)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid"><B>(510)
970-6000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&rsquo;s Telephone Number, Including
Area Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<I>see </I>General Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 2.02. Results of Operations and
Financial Condition. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 28, 2015,
Sangamo BioSciences, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2015. A copy
of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9.01 Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Exhibits. The following material is
filed as an exhibit to this Current Report on Form 8-K:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit No.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">99.1&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release Issued October 28,
2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DATE: October 28, 2015</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SANGAMO BIOSCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 41%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ EDWARD O. LANPHIER II</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Edward O. Lanphier II</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">President, Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v423029_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head><META content="text/html; charset=utf-8"></META></head><body style="font-size:10pt;font-family:Arial;color:black;"><DIV STYLE="width: 100%; margin-left: 10pt; text-align: right"><B>Exhibit
                                         99.1</B></DIV>

<DIV STYLE="width: 100%; margin-left: 10pt">&nbsp;</DIV>

<DIV STYLE="width: 100%; margin-left: 10pt"><p style="text-align:center"><b>Sangamo BioSciences Reports Third Quarter 2015 Financial Results</b></p>
<br /><br />Increases Year End Cash Guidance to Greater Than $200 Million</div><div style="width:100%;margin-left:10pt;"><div style="margin:0;margin-top:16pt;"><p>RICHMOND, Calif., Oct. 28, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its third quarter 2015 financial results and accomplishments.</p><div style="TEXT-ALIGN: left; WIDTH: 100%" id="prni_dvprnejpgbebfleft"><img src="sf35903logo.jpg" id="prnejpgbebfleft" title="Sangamo BioSciences, Inc." border="0" alt="Sangamo BioSciences, Inc." align="middle"></div><p>For the third quarter ended September 30, 2015, Sangamo reported a consolidated net loss of $9.2 million, or $0.13 per share, compared to a net loss of $7.5 million, or $0.11 per share, for the same period in 2014. As of September 30, 2015, the Company had cash, cash equivalents, marketable securities and interest receivable of $219.7
million.</p><p>Revenues for the third quarter of 2015 were $8.6 million, compared to $12.4 million for the same period in 2014. Third quarter 2015 revenues were primarily generated from the Company&#39;s collaboration agreements with Biogen Inc. (Biogen) and Shire International GmbH (Shire). The revenues recognized for the third quarter of 2015 consisted of $8.4 million in collaboration agreements, compared to $12.0 million for the same period in 2014.</p><p>The decrease in collaboration agreement revenues was primarily due to a decrease in revenues under the Company&#39;s collaboration and license agreements with Biogen and Shire as a result of the advancement of our ZFP Therapeutic<sup>&#174;</sup> programs. In the third quarter of 2015, Sangamo recognized $2.6 million of revenues related to research services performed under the collaboration agreement with Biogen, and $3.3 million of
revenues related to research services performed under the collaboration agreement with Shire. In addition, pursuant to the agreements entered into with Shire in January 2012 and Biogen in January 2014, Sangamo received upfront payments of $13.0 million and $20.0 million, respectively. These payments are being recognized as revenue on a straight-line basis over the initial six-year research term for Shire and approximately 40 months for Biogen. The Company recognized $0.5 million of the Shire upfront payment and $1.6 million of the Biogen upfront payment as revenue for the third quarter of 2015.</p><p>Research and development expenses were $16.7 million for the third quarter of 2015, compared to $16.3 million for the same period in 2014. General and administrative expenses were $4.6 million for the third quarter of 2015, compared to $3.7 million for the same period in 2014. Total
operating expenses for the third quarter of 2015 were $21.3 million, compared to $20.1 million for the same period in 2014.</p><p>During the third quarter of 2015, the Company received payment of $14.5 million as a settlement with certain investors who were beneficial owners of Sangamo common stock, related to the disgorgement of short-swing profits pursuant to Section 16 of the Securities and Exchange Act of 1934. Sangamo will recognize a $5.8 million tax benefit related to the settlement payment, of which $3.3 million was recognized in the third quarter of 2015. The remaining tax benefit will be recognized during the fourth quarter of 2015.</p><p><b>Nine Months Results
<br /></b>For the nine months ended September 30, 2015, the consolidated net loss was $26.7 million, or $0.38 per share, compared to a consolidated net loss of $22.1 million, or $0.33 per share, for the nine months ended September 30, 2014. Revenues were $30.4 million for the nine months ended September 30, 2015, compared to $30.9 million for the same period in 2014. Total operating expenses were $61.6 million for the nine months ended September 30, 2015, compared to $53.2 million for the same period in 2014.</p><p><b>Recent Highlights</b></p><ul type="disc">
<li><b>Restructuring of Collaboration Agreement with Shire. </b>In September, Sangamo and its collaborator, Shire, revised their January 2012 collaboration and licensing agreement to accelerate the development of ZFP Therapeutics<sup>&#174;</sup> for hemophilia A and B and Huntington&#39;s disease. Under the amended agreement, Shire returned to Sangamo the exclusive world-wide rights to gene targets for the development, clinical testing and commercialization of ZFP Therapeutics for hemophilia A and B. Shire will continue to develop ZFP Therapeutic clinical leads for Huntington&#39;s disease and one additional gene target yet to be named. The amended agreement reflects a strategic decision by both Sangamo and Shire to focus efforts in areas of current interest and expertise for each company. </li>
<li><b>NIH Recombinant DNA Advisory Committee (RAC) Unanimously Recommends Phase 1 Study Protocol for ZFP Therapeutic for Hemophilia B.</b> In September, Sangamo announced that the National Institutes of Health&#39;s Recombinant DNA advisory Committee (RAC) unanimously approved the Phase 1 study protocol for its Factor IX hemophilia B program. The Factor IX program will be the first clinical study of <i>in vivo</i> genome editing and the first therapeutic application of Sangamo&#39;s In Vivo Protein Replacement Platform&#8482; (IVPRP&#8482;). Sangamo expects to file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) by the end of 2015 and, pending FDA clearance, initiate a Phase 1 clinical trial in 2016. </li>
<li><b>Publication and Presentation of ZFP Therapeutic Program Data Highlight Sangamo&#39;s Genome Editing Platform and Clinical Translation Plans. </b>In September, at this year&#39;s ICAAC meeting, Sangamo presented updated clinical data demonstrating sustained functional control of viral load in the absence of antiretroviral drugs in two of three HIV-infected subjects treated in Cohort 3* of its SB-728-1101 Phase 1/2 study. The subjects remain on extended treatment interruption (TI), past the initial 16 week period. The subjects in Cohort 3* received an SB-728 product that included both CCR5-modified CD4 and CD8 T-cells, after Cytoxan preconditioning, in contrast to patients from other cohorts of the 1101 study who had received only CCR5-modified CD4 T-cells. Data from the Company&#39;s ZFP Therapeutic pipeline were also presented at the annual European Society of Gene and Cell
Therapy (ESGCT) Congress and the Annual Scientific Meeting of the International Society for Experimental Hematology. In addition, preclinical data supporting Sangamo&#39;s hemoglobinopathy programs and its IVPRP program for hemophilia B were published in articles in <i>Nature Methods</i> and <i>Blood</i>, respectively.</li></ul><p><b>Financial Guidance for 2015 </b></p><p>The Company updates guidance as follows:</p><ul type="disc">
<li><b>Cash and Investments:</b> Sangamo expects that its cash, cash equivalents and marketable securities will be at least $200 million at the end of 2015, inclusive of research funding from Biogen and Shire but exclusive of funds arising from any additional new collaborations or partnerships, equity financings or other new sources. The increase in year-end cash balance is primarily due to the above mentioned payment of $14.5 million related to the disgorgement of short-swing profits from certain investors that were beneficial owners of Sangamo common stock. </li>
<li><b>Operating Expenses:</b> Sangamo expects that operating expenses will be in the range of $85 million to $90 million for 2015, due to timing of research and manufacturing expenses related to our preclinical programs. </li></ul><p>The Company reiterates its earlier guidance as follows:</p><ul type="disc">
<li><b>Revenues: </b>Sangamo expects that revenues will be in the range of $35 million to $40 million in 2015, inclusive of research funding from Biogen and Shire. </li></ul><p><b>Conference Call</b></p><p>Sangamo will host a conference call today, October 28, 2015, at 5:00 p.m. ET, which will be open to the public. The call will also be webcast live and can be accessed via a link on the Sangamo BioSciences website in the Investor Relations section under &#34;Events and Presentations&#34; http://investor.sangamo.com/events.cfm.  A replay of the webcast will also be available for two weeks after the call. During the conference call, the Company will review these results, discuss other business matters and provide guidance with respect to the rest of 2015.</p><p>The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The
conference ID number for the call is 60977672. For those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call, from approximately 8:00 p.m. ET on October 28, 2015 to 11:59 p.m. ET on November 3, 2015. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 60977672.</p><p><b>About Sangamo
<br /></b>Sangamo BioSciences, Inc. is focused on Engineering Genetic Cures&#8482; for monogenic and infectious diseases by deploying its novel DNA-binding protein technology platform in therapeutic genome editing and gene regulation. The Company has a Phase 2 clinical program to evaluate the safety and efficacy of novel ZFP Therapeutics<sup>&#174;</sup> for the treatment of HIV/AIDS (SB-728). Sangamo&#39;s other therapeutic programs are focused on monogenic and rare diseases. The Company has formed a strategic collaboration with Biogen Inc. for hemoglobinopathies, such as sickle cell disease and beta-thalassemia, and with Shire International GmbH to develop therapeutics for Huntington&#39;s disease. It has also established strategic partnerships with companies in non-therapeutic applications of its technology, including Dow AgroSciences and Sigma-Aldrich Corporation. For more
information about Sangamo, visit the Company&#39;s website at www.sangamo.com.</p><p><i>ZFP Therapeutic</i><i><sup>&#174;</sup></i><i> is a registered trademark of Sangamo BioSciences, Inc.</i></p><p><i>This press release contains forward-looking statements regarding Sangamo&#39;s current expectations.  These forward looking statements include, without limitation, references to anticipated cash and investment balance, operating expenses, revenue, the research and development of </i><i>ZFNs and  ZFP TFs, clinical trials and therapeutic applications of Sangamo&#39;s ZFP technology platform and achievement of research milestones and objectives under collaboration agreements with Shire and Biogen</i><i>. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual
results to differ include, but are not limited to, the early stage of ZFP Therapeutic development, the lengthy and uncertain regulatory approval process, uncertainties related to the timing of initiation and completion of clinical trials, whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics, and the ability to establish strategic partnerships.  Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo and its partners will be able to develop commercially viable gene-based therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in Sangamo&#39;s operations and business environments. These risks and uncertainties are described more fully in Sangamo&#39;s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q
as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Sangamo undertakes no duty to update such information except as required under applicable law.</i></p><p> </p><div>
<div><table style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt" border="0" cellspacing="0" cellpadding="0"><tr><td colspan="8" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"><b>SELECTED CONSOLIDATED FINANCIAL DATA</b></font></font></p></td></tr><tr><td colspan="8" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(in thousands, except per share
data)</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td colspan="2" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"><b>Statement of Operations Data:</b></font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td colspan="3" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160;Three Months Ended&#160;&#160;</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td colspan="3" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160;Nine Months Ended&#160;&#160;</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td colspan="3" style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160;September 30,&#160;</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td colspan="3" style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160;September 30,&#160;</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2015</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2014</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2015</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2014</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Revenues:</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160; Collaboration agreements</font></font></p></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;8,406</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP:
1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160;12,045</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160;28,878</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160;29,334</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160; Research grants</font></font></p></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">163</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">372</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">1,540</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">1,584</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160;&#160;&#160; Total revenues</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">8,569</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">12,417</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">30,418</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">30,918</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Operating expenses:</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 12px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Research and development</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">16,694</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">16,340</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">47,292</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">41,883</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 12px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">General and administrative</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">4,560</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">3,731</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">14,309</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">11,347</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 24px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Total operating expenses</font></font></p></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN:
0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">21,254</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">20,071</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">61,601</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">53,230</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Loss from operations</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN:
0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(12,685)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(7,654)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(31,183)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(22,312)</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Interest and other income, net</font></font></p></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">101</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">109</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">406</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">214</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Loss before taxes</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(12,584)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(7,545)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(30,777)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(22,098)</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Benefit from income taxes</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">3,339</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">0</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">4,087</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">0</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Net loss</font></font></p></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; (9,245)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;(7,545)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$(26,690)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$(22,098)</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Basic and diluted net loss per common share</font></font></p></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt;
VERTICAL-ALIGN: bottom; BORDER-TOP: black 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; (0.13)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;(0.11)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160;(0.38)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160;(0.33)</font></font></p></td></tr><tr><td rowspan="2" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Shares used in computing basic and diluted net loss per&#160;</font><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">common share</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN:
right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">69,892</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">68,230</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">69,622</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">66,488</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td colspan="2" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"><b>SELECTED BALANCE SHEET DATA</b></font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">September 30, 2015</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">December 31, 2014</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(Unaudited)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Cash, cash equivalents, marketable securities and interest receivable</font></font></p></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;219,728</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt;
PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160;226,645</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Total assets</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">232,516</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">243,212</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Total stockholders&#39; equity</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">203,558</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">206,633</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr></table></div></div><p> </p><p>Logo - http://photos.prnewswire.com/prnh/20130102/SF35903LOGO </p><p> </p><p>
<br /></p>
<br /><br /><p>CONTACT: Sangamo BioSciences, Inc., Elizabeth Wolffe, Ph.D., (510) 970-6000, x271, OR, Varant Shirvanian, (510) 970-6000, x205</p></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>sf35903logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sf35903logo.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" !; 9 # 2(  A$! Q$!_\0
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M.T@[;R0%LD%?TB_X+17]G\0OV+?A3XZ\-746J>&[[XJ>!_%UAJ$ 9[>]\/\
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M,>!,ZX7\(O&["YBZ5#!X?B.ECLJY*D9SC&KC5!Q?*_<M&#M%*,KN[NM'^&\
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M7ABEWDG-N1@$'/\ .I_P3QNA\6O^"F-MXWL#(MIKGC+XT_$9;F,;?)TO6O\
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M+M%\."XMK1IO%GPM\$3>';B660>79W%]HFDL+>YDC^4(US&Q8_(^[ /[5_\
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M:VFQ_%K6;6(^$=,U/1I];M6\+P7GDR1RVMK=?Z/LVL#M;J17[[6,C)8VVX2
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M'>&?C;\:/%E[KLFB:#X_\2>*/%>LR^?=OI?AC5_$$DMU<W$QP%ATJP5$+$(
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M4EE"D?VGX@O;/3=2N ?XMU[XJE'&2?-SR 2/8_\ @N9XGOO%G[0GP/\ A?I
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MZ;_PDWDRV\<\5Q<:]XJO-)WR;\@K8OO (V[9-Q((JWX%^&__  5__8_TN_\
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MCGUBNM6U:0=L7V.H->%?\%[XXE^*/[.LX7$LO@;QZCL?[D.O^'D7..I+,/\
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M<ONVM[BO'_"[Z?.[\PA'E6C<9O[7--N/I>7O?.W8SXXMD)0K+MSQ'*ZY49)
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M42TY*+CS:=$FXV7:]V_T\C*,$#E3(DFX#Y)%,L?EE"2"C*V8SR>1C.<'BG)
M)-RR^85)8G$R-G))! 5<KCH.]:0AC!!" $ @')X!Z]Z7RTY&T#/7'&?RINF[
M1BG'DCLG33Y5VBW+3\=2>5R</:>^ELW*;E'R3NN;U:78J,BNNU5XSRC,Z <G
M[H!P!P0?4'!R,BGV\(C8D$DE2",18R2O0QQKCA0,#CCIGFK(10, <?4_XTH
D'3^M/D]Y23<?[MHN/R;CS+Y-%)2Y8J4N9QZV<;^MI-/YG__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
